TADALAFIL PAH OrPha cpr pell 20 mg 56 pce

7680679680012 CH-67968 G04BE08 02.07.1.

Reimbursement limitations:

TADALA.P.OrP

Garantie de prise en charge des coûts par l'assureur-maladie après consultation préalable du médecin-conseil sur …

TADALAFIL PAH OrPha cpr pell 20 mg 56 pce
TADALAFIL PAH OrPha cpr pell 20 mg 56 pce
TADALAFIL PAH OrPha cpr pell 20 mg 56 pce
1 / 3
google

Details

Product number
6796801
CPT
-
Packaging group
56
Unit
Tablette(n)
Composition
tadalafilum 20 mg, lactosum 312.5 mg, carmellosum natricum conexum, natrii laurilsulfas, hydroxypropylcellulosum, polysorbatum 80, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.8 mg, E 171, triacetinum, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 1.91 mg.

Articles (1)

Tadalafil PAH OrPha 20 mg, Filmtabletten
Filmtabletten
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/01/2024
Patient information leaflet
Français
03/01/2024
Patient information leaflet
Italien
03/01/2024
Professional SmPC
Allemand
03/01/2024
Professional SmPC
Français
03/01/2024
Professional SmPC
Italien
03/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
312.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.8 MG Substance HBESI
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
1.91 MG Substance HBESI

Reimbursement information

Public price
CHF 511.30
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2021

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
67968
Drug name
Tadalafil PAH OrPha, Filmtabletten
Galenic form
FILM
ATC Code
G04BE08
Authorization status
Z
Dispensation category
B
First authorization
23/07/2020
Authorization expiration date
31/12/9999
IT number
02.07.1.
Domain
Human medicine
Field of application
Pulmonale arterielle Hypertonie

Packaging details

Description (FR)
TADALAFIL PAH OrPha cpr pell 20 mg 56 pce
Description (DE)
TADALAFIL PAH OrPha Filmtabl 20 mg 56 Stk
Market launch
23/07/2020
Narcotic (BTM)
No

Original drug

Adcirca, comprimés pelliculés
CHF 563.15
View original